
`@miles 9/9/2022 3:41 PM UTC`

[轉發自GETTR](https://gettr.com/post/p1qa00maaea)

9/8/2022: Fay Fay Show: Guo Guangchang’s Fosun Pharma is in bad shape and has heavy debts. Moody’s credit rating agency has downgraded its rating from Ba3 to B1.

9/8/2022 飞飞秀：郭广昌的公司经营不佳，债台高筑。穆迪信用评级机构将复星国际的评级从Ba3降到了B1。


![img](https://media.gettr.com/group16/getter/2022/09/09/15/b7f8f8b8-82f2-7429-2dd0-c3b50d35f0f0/out.jpg)
